1-4 of 4
Stefan Tenzer
Close
Sort by
Journal Articles

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Pamela Stein, PhD, Karsten Gogoll, PhD, Tanja Peters, PhD, Mark Denny, Stefan Tenzer, PhD, Stefan Stevanovic, PhD, Hansjoerg Schild, PhD Prof., Matthias Theobald, MD PhD, Peter Langguth, Markus Radsak, MD
Journal: Blood
Blood (2015) 126 (23): 2224.
https://doi.org/10.1182/blood.V126.23.2224.2224
Published: 2015
Journal Articles

The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells

Stefanie AE Held, Annkristin Heine, MD, Stefan Tenzer, PhD, Anita Bringmann, PhD, Hansjoerg Schild, MD, Prof., Christoph Driessen, MD, Peter Brossart, MD
Journal: Blood
Blood (2011) 118 (21): 2748.
https://doi.org/10.1182/blood.V118.21.2748.2748
Published: 2011
Journal Articles

Imatinib Mesylate and Nilotinib Affect the MHC-Class I Presentation by Modulating the Proteasomal Processing of Antigenic Peptides.

Stefanie Held, Stefan Tenzer, Thomas Rückrich, Karin von Schwarzenberg, Anita Bringmann, Annkristin Heine, Hansjörg Schild, Christoph Driessen, MD, Peter Brossart, MD
Journal: Blood
Blood (2009) 114 (22): 2169.
https://doi.org/10.1182/blood.V114.22.2169.2169
Published: 2009
Journal Articles

A neoepitope generated by an FLT3 internal tandem duplication ( FLT3-ITD ) is recognized by leukemia-reactive autologous CD8 + T cells

Brief Report
Claudine Graf, Florian Heidel, Stefan Tenzer, Markus P. Radsak, Fian K. Solem, Cedrik M. Britten, Christoph Huber, Thomas Fischer, Thomas Wölfel
Journal: Blood
Blood (2006) 109 (7): 2985–2988.
https://doi.org/10.1182/blood-2006-07-032839
Published: 2006
Includes: Supplemental data